About
We are at a tipping point. The convergence of genomics and digital data is enabling the development of superior therapeutics, diagnostics, and delivery models. Breakthrough science is transforming medicine into a value-based healthcare system, leading to lower costs and better patient outcomes.
Biomatics helps create the next generation of companies that will lead this transformation.
Healthcare & Life SciencesVenture Capital & Private Equity
Investment criteria
Pre-seed
—
Seed
Invests
Series A
Invests
Series B
Invests
Growth
—
- Sectors
- Healthcare & Life SciencesVenture Capital & Private Equity
- Geographies
- United States
- Round role
- Leads and co-leads rounds
Highlights
Highlights coming soon
Notable work and milestones will show up here.

